IPOs

Poor fourth quarter mars strong year for medtech floats
Poor fourth quarter mars strong year for medtech floats
EP Vantage
devices
IPOs
Envista
Smile Direct Club
Medacta
Livongo
Silk Road Medical
Adaptive Biotechnologies
Shockwave Medical
TransMedics
Castle Biosciences
Exagen
Flag link:
Will This Be the Next Big Healthcare IPO?
Will This Be the Next Big Healthcare IPO?
Motley Fool
One Medical
IPOs
Flag link:
After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO
After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO
Fierce Biotech
IPOs
China
NASDAQ
I-Mab Biopharma
autoimmune disease
cancer
Flag link:
Mixed fortunes greet listing medtechs
Mixed fortunes greet listing medtechs
EP Vantage
devices
IPOs
Flag link:
ADiTxT Therapeutics Files for $25 Million IPO
ADiTxT Therapeutics Files for $25 Million IPO
CP WIre
ADiTxT
organ transplantation
immunosupression
IPOs
Flag link:
ADiTxT Therapeutics Files for $25 Million IPO
ADiTxT
organ transplantation
immunosupression
IPOs
Flag link:
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans
Xconomy
gene therapy
IPOs
Generation Bio
Flag link:
Shooting for $100M IPO, Schrödinger takes the wraps off its five internal drugs and discloses deal details
Shooting for $100M IPO, Schrödinger takes the wraps off its five internal drugs and discloses deal details
Endpoints
Schrödinger
IPOs
Flag link:
PPD Files the Paperwork for $100 Million IPO
PPD Files the Paperwork for $100 Million IPO
CP WIre
PPD
CROs
IPOs
Flag link:
PPD Files the Paperwork for $100 Million IPO
PPD
CROs
IPOs
Flag link:
Arcutis Biotherapeutics Files for $100 Million IPO
Arcutis Biotherapeutics Files for $100 Million IPO
CP Wire
Arcutis Biotherpeutics
IPOs
ARQ-151
chronic plaque psoriasis
Flag link:
Arcutis Biotherapeutics Files for $100 Million IPO
Arcutis Biotherpeutics
IPOs
ARQ-151
chronic plaque psoriasis
Flag link:
The first biotech IPO of the new decade has landed — and of course it's another cancer drug developer
The first biotech IPO of the new decade has landed — and of course it's another cancer drug developer
Endpoints
Black Diamond Therapeutics
IPOs
oncology
cancer
I-Mab Biopharma
Flag link:
Avadim Health Files for $50 Million IPO
Avadim Health Files for $50 Million IPO
CP WIre
IPOs
Avadim Health
Flag link:
Avadim Health Files for $50 Million IPO
Avadim Health
IPOs
Flag link:
If You Invested $10,000 in Johnson & Johnson's IPO, This Is How Much Money You'd Have Now
If You Invested $10,000 in Johnson & Johnson's IPO, This Is How Much Money You'd Have Now
Motley Fool
JNJ
IPOs
pharma stocks
Flag link:
3 trends in biotech to watch in 2020
3 trends in biotech to watch in 2020
Stat
IPOs
eteplirsen
CAR-T
gene therapy
cell therapy
biotech
Flag link:
A Look at 5 Big and Interesting Biotech IPOs for 2019
A Look at 5 Big and Interesting Biotech IPOs for 2019
BioSpace
IPOs
NASDAQ
Adaptive Biotechnologies
Genmab
Gossamer Bio
BridgeBio
Alector
Flag link:
Election 2020: What will it mean for R&D?
Election 2020: What will it mean for R&D?
Fierce Biotech
2020 Presidential election
IPOs
R&D
Flag link:
This Start-up Might Be the Next Gene Editing IPO
This Start-up Might Be the Next Gene Editing IPO
Motley Fool
gene editing
Beam Therapeutics
IPOs
CRISPR
Flag link:

Pages